|
OMIM |
Link |
Information gain |
01 |
|
apnea, obstructive sleep
|
[NCBI]
|
0.0169425
|
|
|
RA
|
[NCBI]
|
0.00347584
|
|
|
IS1
|
[NCBI]
|
0.00269936
|
|
|
MAFD1
|
[NCBI]
|
0.00240082
|
|
|
migraine, familial typical, susceptibility to, 2
|
[NCBI]
|
0.0022353
|
|
|
CF
|
[NCBI]
|
0.00201696
|
|
|
SLE
|
[NCBI]
|
0.0018887
|
|
|
alzheimer disease 5
|
[NCBI]
|
0.00186113
|
|
|
parkinson disease 12
|
[NCBI]
|
0.00178777
|
|
|
PARK11
|
[NCBI]
|
0.00178777
|
|
|
SCZD3
|
[NCBI]
|
0.00170622
|
|
|
stature quantitative trait locus 5
|
[NCBI]
|
0.00134047
|
|
|
body mass index quantitative trait locus on chromosome 6
|
[NCBI]
|
0.00134047
|
|
|
prostate cancer, hereditary, 3
|
[NCBI]
|
0.00134047
|
|
|
alzheimer disease 11
|
[NCBI]
|
0.00134047
|
|
|
IDDM3
|
[NCBI]
|
0.00134047
|
|
|
stature quantitative trait locus 2
|
[NCBI]
|
0.00134047
|
|
|
body mass index quantitative trait locus on chromosome 11
|
[NCBI]
|
0.00134047
|
|
|
amyotrophic lateral sclerosis 6
|
[NCBI]
|
0.00134047
|
|
|
OFC2
|
[NCBI]
|
0.00134047
|
|
|
graves disease, susceptibility to, 2
|
[NCBI]
|
0.0013285
|
|
|
hereditary motor and sensory neuropathy, type iic
|
[NCBI]
|
0.0013285
|
|
|
PSORS2
|
[NCBI]
|
0.00120795
|
|
|
IBD2
|
[NCBI]
|
0.00113002
|
|
|
stature as a quantitative trait
|
[NCBI]
|
0.00109594
|
|
|
NIDDM2
|
[NCBI]
|
0.00109594
|
|
|
ICCA
|
[NCBI]
|
0.000929571
|
|
|
MYP3
|
[NCBI]
|
0.000929571
|
|
|
obesity quantitative trait locus on chromosome 20
|
[NCBI]
|
0.000929571
|
|
|
SLEB3
|
[NCBI]
|
0.000929571
|
|
|
DFN4
|
[NCBI]
|
0.000929571
|
|
|
acute myelogenous leukemia
|
[NCBI]
|
0.000893408
|
|
|
myopia 9
|
[NCBI]
|
0.000893408
|
|
|
myopia 7
|
[NCBI]
|
0.000893408
|
|
|
convulsions, benign familial infantile, 2
|
[NCBI]
|
0.000893408
|
|
|
migraine with or without aura, susceptibility to, 10
|
[NCBI]
|
0.000893408
|
|
|
FSHMD1B
|
[NCBI]
|
0.000893408
|
|
|
diabetes mellitus, noninsulin-dependent, 4
|
[NCBI]
|
0.000893408
|
|
|
SLI2
|
[NCBI]
|
0.000893408
|
|
|
myopia 8
|
[NCBI]
|
0.000893408
|
|
|
SLI1
|
[NCBI]
|
0.000893408
|
|
|
melanoma, cutaneous malignant, 4
|
[NCBI]
|
0.000893408
|
|
|
myopia 5
|
[NCBI]
|
0.000893408
|
|
|
PEE2
|
[NCBI]
|
0.000893408
|
|
|
obesity, susceptibility to, on chromosome 4
|
[NCBI]
|
0.000893408
|
|
|
myopia 14
|
[NCBI]
|
0.000893408
|
|
|
systemic lupus erythematosus, susceptibility to, 8
|
[NCBI]
|
0.000893408
|
|
|
IDDM8
|
[NCBI]
|
0.000893408
|
|
|
GLC1I
|
[NCBI]
|
0.000893408
|
|
|
migraine with or without aura, susceptibility to, 11
|
[NCBI]
|
0.000893408
|
|
|
porokeratosis, disseminated superficial actinic, 2
|
[NCBI]
|
0.000893408
|
|
|
SLI3
|
[NCBI]
|
0.000893408
|
|
|
thyroid carcinoma, papillary, with papillary renal neoplasia
|
[NCBI]
|
0.000893408
|
|
|
myopia 10
|
[NCBI]
|
0.000893408
|
|
|
ichthyosis prematurity syndrome
|
[NCBI]
|
0.000893408
|
|
|
restless legs syndrome, susceptibility to, 2
|
[NCBI]
|
0.000893408
|
|
|
IBD7
|
[NCBI]
|
0.000893408
|
|
|
DYX9
|
[NCBI]
|
0.000893408
|
|
|
MNG2
|
[NCBI]
|
0.000893408
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
0.000804541
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
0.000736753
|
|
|
SPG12
|
[NCBI]
|
0.000735554
|
|
|
coronary heart disease, susceptibility to, 2
|
[NCBI]
|
0.000735554
|
|
|
SCA4
|
[NCBI]
|
0.000735554
|
|
|
MRX3
|
[NCBI]
|
0.000735554
|
|
|
migraine with or without aura, susceptibility to, 5
|
[NCBI]
|
0.000735554
|
|
|
PARK3
|
[NCBI]
|
0.000616684
|
|
|
HPCX
|
[NCBI]
|
0.000616684
|
|
|
CCA1
|
[NCBI]
|
0.000603122
|
|
|
HMN7A
|
[NCBI]
|
0.000603122
|
|
|
HFM
|
[NCBI]
|
0.000578719
|
|
|
orofacial cleft 4
|
[NCBI]
|
0.000547545
|
|
|
migraine with or without aura, susceptibility to, 3
|
[NCBI]
|
0.000547545
|
|
|
cataract, autosomal recessive, early-onset, pulverulent
|
[NCBI]
|
0.000547545
|
|
|
PSORS3
|
[NCBI]
|
0.000547545
|
|
|
MCOPS4
|
[NCBI]
|
0.000547545
|
|
|
PARK10
|
[NCBI]
|
0.000547545
|
|
|
restless legs syndrome, susceptibility to, 3
|
[NCBI]
|
0.000547545
|
|
|
cataract, central saccular, with sutural opacities
|
[NCBI]
|
0.000547545
|
|
|
systemic lupus erythematosus, susceptibility to, 7
|
[NCBI]
|
0.000547545
|
|
|
ALS3
|
[NCBI]
|
0.000547545
|
|
|
graves disease, susceptibility to, x-linked
|
[NCBI]
|
0.000547545
|
|
|
van der woude syndrome modifier
|
[NCBI]
|
0.000547545
|
|
|
IDDM13
|
[NCBI]
|
0.000547545
|
|
|
migraine without aura, susceptibility to, 4
|
[NCBI]
|
0.000547545
|
|
|
myopia 6
|
[NCBI]
|
0.000547545
|
|
|
stature quantitative trait locus 8
|
[NCBI]
|
0.000547545
|
|
|
IBD6
|
[NCBI]
|
0.000547545
|
|
|
wilms tumor 4
|
[NCBI]
|
0.000547545
|
|
|
IDDM11
|
[NCBI]
|
0.000547545
|
|
|
IDDM15
|
[NCBI]
|
0.000547545
|
|
|
vacuolar neuromyopathy
|
[NCBI]
|
0.000547545
|
|
|
CMD1F
|
[NCBI]
|
0.000547545
|
|
|
IBD9
|
[NCBI]
|
0.000547545
|
|
|
hypotrichosis, marie unna type
|
[NCBI]
|
0.000503666
|
|
|
SPG5A
|
[NCBI]
|
0.000503666
|
|
|
duane retraction syndrome 2
|
[NCBI]
|
0.000503666
|
|
|
thyroid carcinoma, nonmedullary, with or without cell oxyphilia
|
[NCBI]
|
0.000503666
|
|
|
MAFD2
|
[NCBI]
|
0.000502139
|
|
|
CRC
|
[NCBI]
|
0.000477653
|
|
|
coronary heart disease, susceptibility to, 1
|
[NCBI]
|
0.000446586
|
|
|
creatinine clearance quantitative trait locus
|
[NCBI]
|
0.000446586
|
|
|
intelligence quantitative trait locus 2
|
[NCBI]
|
0.000446586
|
|
|
FEB7
|
[NCBI]
|
0.000446586
|
|
|
KTCN2
|
[NCBI]
|
0.000446586
|
|
|
DFNB44
|
[NCBI]
|
0.000446586
|
|
|
retinitis pigmentosa 34
|
[NCBI]
|
0.000446586
|
|
|
KTCN3
|
[NCBI]
|
0.000446586
|
|
|
leukemia, chronic lymphocytic, susceptibility to, 1
|
[NCBI]
|
0.000446586
|
|
|
DSMA2
|
[NCBI]
|
0.000446586
|
|
|
attention deficit-hyperactivity disorder, susceptibility to, 3
|
[NCBI]
|
0.000446586
|
|
|
BMND4
|
[NCBI]
|
0.000446586
|
|
|
DFNB66
|
[NCBI]
|
0.000446586
|
|
|
FMTLE
|
[NCBI]
|
0.000446586
|
|
|
DFNB35
|
[NCBI]
|
0.000446586
|
|
|
panic disorder 2
|
[NCBI]
|
0.000446586
|
|
|
nephropathy, progressive, with deafness
|
[NCBI]
|
0.000446586
|
|
|
AD15
|
[NCBI]
|
0.000446586
|
|
|
acropectorovertebral dysplasia, f-form of
|
[NCBI]
|
0.000446586
|
|
|
GLC1N
|
[NCBI]
|
0.000446586
|
|
|
GLC1K
|
[NCBI]
|
0.000446586
|
|
|
MRT4
|
[NCBI]
|
0.000446586
|
|
|
myoclonic epilepsy, infantile
|
[NCBI]
|
0.000446586
|
|
|
HSCR5
|
[NCBI]
|
0.000446586
|
|
|
MCS
|
[NCBI]
|
0.000446586
|
|
|
MSSD
|
[NCBI]
|
0.000446586
|
|
|
GLC1F
|
[NCBI]
|
0.000446586
|
|
|
renal hypodysplasia, nonsyndromic, 1
|
[NCBI]
|
0.000446586
|
|
|
foveal hypoplasia and anterior segment dysgenesis
|
[NCBI]
|
0.000446586
|
|
|
stature quantitative trait locus 7
|
[NCBI]
|
0.000446586
|
|
|
IBD8
|
[NCBI]
|
0.000446586
|
|
|
body mass index quantitative trait locus on chromosome 7
|
[NCBI]
|
0.000446586
|
|
|
DFNA25
|
[NCBI]
|
0.000446586
|
|
|
GINGF2
|
[NCBI]
|
0.000446586
|
|
|
gallbladder disease 3
|
[NCBI]
|
0.000446586
|
|
|
alzheimer disease 12
|
[NCBI]
|
0.000446586
|
|
|
SPG30
|
[NCBI]
|
0.000446586
|
|
|
WM2
|
[NCBI]
|
0.000446586
|
|
|
psoriasis susceptibility 9
|
[NCBI]
|
0.000446586
|
|
|
SQTL2
|
[NCBI]
|
0.000446586
|
|
|
GINGF4
|
[NCBI]
|
0.000446586
|
|
|
MRX73
|
[NCBI]
|
0.000446586
|
|
|
preauricular tag, isolated, autosomal dominant, 1
|
[NCBI]
|
0.000446586
|
|
|
MMVP3
|
[NCBI]
|
0.000446586
|
|
|
MRX53
|
[NCBI]
|
0.000446586
|
|
|
migraine with aura, susceptibility to, 9
|
[NCBI]
|
0.000446586
|
|
|
diamond-blackfan anemia 2
|
[NCBI]
|
0.000446586
|
|
|
acropectoral syndrome
|
[NCBI]
|
0.000446586
|
|
|
RP23
|
[NCBI]
|
0.000446586
|
|
|
plasmodium falciparum fever episodes quantitative trait locus 1
|
[NCBI]
|
0.000446586
|
|
|
EIG4
|
[NCBI]
|
0.000446586
|
|
|
STHAG5
|
[NCBI]
|
0.000446586
|
|
|
CORDX2
|
[NCBI]
|
0.000446586
|
|
|
STGD4
|
[NCBI]
|
0.000446586
|
|
|
EJM4
|
[NCBI]
|
0.000446586
|
|
|
restless legs syndrome, susceptibility to, 5
|
[NCBI]
|
0.000446586
|
|
|
prostate cancer, hereditary, 7
|
[NCBI]
|
0.000446586
|
|
|
DFNB40
|
[NCBI]
|
0.000446586
|
|
|
AGMX2
|
[NCBI]
|
0.000446586
|
|
|
RP25
|
[NCBI]
|
0.000446586
|
|
|
PEE3
|
[NCBI]
|
0.000446586
|
|
|
DFNB26
|
[NCBI]
|
0.000446586
|
|
|
SPG28
|
[NCBI]
|
0.000446586
|
|
|
EIG2
|
[NCBI]
|
0.000446586
|
|
|
exfoliative ichthyosis, autosomal recessive, ichthyosis bullosa of siemens-like
|
[NCBI]
|
0.000446586
|
|
|
GLC1J
|
[NCBI]
|
0.000446586
|
|
|
peripheral arterial occlusive disease 1
|
[NCBI]
|
0.000446586
|
|
|
ciliary dyskinesia, primary, 5
|
[NCBI]
|
0.000446586
|
|
|
armfield x-linked mental retardation syndrome
|
[NCBI]
|
0.000446586
|
|
|
HSCR8
|
[NCBI]
|
0.000446586
|
|
|
BMND7
|
[NCBI]
|
0.000446586
|
|
|
DFNB39
|
[NCBI]
|
0.000446586
|
|
|
CTPP5
|
[NCBI]
|
0.000446586
|
|
|
DFNA16
|
[NCBI]
|
0.000446586
|
|
|
hodgkin disease, y-linked pseudoautosomal
|
[NCBI]
|
0.000446586
|
|
|
DFNB62
|
[NCBI]
|
0.000446586
|
|
|
AIS4
|
[NCBI]
|
0.000446586
|
|
|
deafness, congenital neurosensory, autosomal recessive 38
|
[NCBI]
|
0.000446586
|
|
|
hypertensive nephropathy
|
[NCBI]
|
0.000446586
|
|
|
spondyloarthropathy, susceptibility to, 2
|
[NCBI]
|
0.000446586
|
|
|
SCA23
|
[NCBI]
|
0.000446586
|
|
|
LKE
|
[NCBI]
|
0.000446586
|
|
|
restless legs syndrome, susceptibility to, 4
|
[NCBI]
|
0.000446586
|
|
|
SQTL1
|
[NCBI]
|
0.000446586
|
|
|
van der woude syndrome 2
|
[NCBI]
|
0.000446586
|
|
|
DFNA30
|
[NCBI]
|
0.000446586
|
|
|
DFNB55
|
[NCBI]
|
0.000446586
|
|
|
cataract, crystalline coralliform
|
[NCBI]
|
0.000446586
|
|
|
MRX72
|
[NCBI]
|
0.000446586
|
|
|
hypotrichosis simplex
|
[NCBI]
|
0.000446586
|
|
|
gallbladder disease 2
|
[NCBI]
|
0.000446586
|
|
|
amyotrophic lateral sclerosis 7
|
[NCBI]
|
0.000446586
|
|
|
cataract, nuclear progressive
|
[NCBI]
|
0.000446586
|
|
|
body mass index quantitative trait locus on chromosome 13
|
[NCBI]
|
0.000446586
|
|
|
abidi x-linked mental retardation syndrome
|
[NCBI]
|
0.000446586
|
|
|
polydactyly, postaxial, type a3
|
[NCBI]
|
0.000446586
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 2
|
[NCBI]
|
0.000446586
|
|
|
mycobacterium tuberculosis, susceptibility to, 1
|
[NCBI]
|
0.000446586
|
|
|
DFNB63
|
[NCBI]
|
0.000446586
|
|
|
noncompaction of left ventricular myocardium, familial isolated, autosomal dominant 2
|
[NCBI]
|
0.000446586
|
|
|
SCKL2
|
[NCBI]
|
0.000446586
|
|
|
RP28
|
[NCBI]
|
0.000446586
|
|
|
hypertension, essential, susceptibility to, 4
|
[NCBI]
|
0.000446586
|
|
|
MRX52
|
[NCBI]
|
0.000446586
|
|
|
lung cancer 1
|
[NCBI]
|
0.000446586
|
|
|
myopia 11
|
[NCBI]
|
0.000446586
|
|
|
BMND6
|
[NCBI]
|
0.000446586
|
|
|
SLEN1
|
[NCBI]
|
0.000446586
|
|
|
aortic aneurysm, familial abdominal 1
|
[NCBI]
|
0.000446586
|
|
|
AMCX5
|
[NCBI]
|
0.000446586
|
|
|
GLC1B
|
[NCBI]
|
0.000446586
|
|
|
attention deficit-hyperactivity disorder, susceptibility to, 4
|
[NCBI]
|
0.000446586
|
|
|
GLC1D
|
[NCBI]
|
0.000446586
|
|
|
SCA18
|
[NCBI]
|
0.000446586
|
|
|
PORC
|
[NCBI]
|
0.000446586
|
|
|
ciliary dyskinesia, primary, 4
|
[NCBI]
|
0.000446586
|
|
|
DFNA47
|
[NCBI]
|
0.000446586
|
|
|
schizophrenia 12
|
[NCBI]
|
0.000446586
|
|
|
PFM3
|
[NCBI]
|
0.000446586
|
|
|
SCA28
|
[NCBI]
|
0.000446586
|
|
|
DFNA43
|
[NCBI]
|
0.000446586
|
|
|
LAH3
|
[NCBI]
|
0.000446586
|
|
|
intelligence quantitative trait locus 3
|
[NCBI]
|
0.000446586
|
|
|
DFNM1
|
[NCBI]
|
0.000446586
|
|
|
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 2
|
[NCBI]
|
0.000446586
|
|
|
prostate cancer, hereditary, 5
|
[NCBI]
|
0.000446586
|
|
|
OTSC4
|
[NCBI]
|
0.000446586
|
|
|
autoimmune thyroid disease, susceptibility to, 4
|
[NCBI]
|
0.000446586
|
|
|
EMWX
|
[NCBI]
|
0.000446586
|
|
|
moyamoya disease 3
|
[NCBI]
|
0.000446586
|
|
|
OTSC2
|
[NCBI]
|
0.000446586
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 3
|
[NCBI]
|
0.000446586
|
|
|
GLC1H
|
[NCBI]
|
0.000446586
|
|
|
high density lipoprotein deficiency 3
|
[NCBI]
|
0.000446586
|
|
|
muscular dystrophy, congenital, 1b
|
[NCBI]
|
0.000446586
|
|
|
CATCN1
|
[NCBI]
|
0.000446586
|
|
|
alopecia-mental retardation syndrome 2
|
[NCBI]
|
0.000446586
|
|
|
MENAQ1
|
[NCBI]
|
0.000446586
|
|
|
DFNA24
|
[NCBI]
|
0.000446586
|
|
|
ATFB2
|
[NCBI]
|
0.000446586
|
|
|
OTSC5
|
[NCBI]
|
0.000446586
|
|
|
PNKD2
|
[NCBI]
|
0.000446586
|
|
|
OTSC3
|
[NCBI]
|
0.000446586
|
|
|
SLEN3
|
[NCBI]
|
0.000446586
|
|
|
GINGF3
|
[NCBI]
|
0.000446586
|
|
|
dyskeratosis, hereditary benign intraepithelial
|
[NCBI]
|
0.000446586
|
|
|
hematocrit/hemoglobin quantitative trait locus on chromosome 6
|
[NCBI]
|
0.000446586
|
|
|
narcolepsy 2
|
[NCBI]
|
0.000446586
|
|
|
SLEN2
|
[NCBI]
|
0.000446586
|
|
|
FEB6
|
[NCBI]
|
0.000446586
|
|
|
MYMY2
|
[NCBI]
|
0.000446586
|
|
|
aortic aneurysm, familial abdominal 2
|
[NCBI]
|
0.000446586
|
|
|
SCAR7
|
[NCBI]
|
0.000446586
|
|
|
stature quantitative trait locus 4
|
[NCBI]
|
0.000446586
|
|
|
FGS4
|
[NCBI]
|
0.000446586
|
|
|
aneurysm, intracranial berry, 2
|
[NCBI]
|
0.000446586
|
|
|
generalized epilepsy with febrile seizures plus, type 4
|
[NCBI]
|
0.000446586
|
|
|
coronary heart disease, susceptibility to, 4
|
[NCBI]
|
0.000446586
|
|
|
prostate cancer, hereditary, 4
|
[NCBI]
|
0.000446586
|
|
|
HDLCQ1
|
[NCBI]
|
0.000446586
|
|
|
DFNB68
|
[NCBI]
|
0.000446586
|
|
|
coronary heart disease, susceptibility to, 3
|
[NCBI]
|
0.000446586
|
|
|
DFNA53
|
[NCBI]
|
0.000446586
|
|
|
SPG29
|
[NCBI]
|
0.000446586
|
|
|
mental retardation, truncal obesity, retinal dystrophy, and micropenis
|
[NCBI]
|
0.000446586
|
|
|
narcolepsy 3
|
[NCBI]
|
0.000446586
|
|
|
longevity 1
|
[NCBI]
|
0.000446586
|
|
|
SCZD9
|
[NCBI]
|
0.000438447
|
|
|
IDDM4
|
[NCBI]
|
0.000427396
|
|
|
pulmonary disease, chronic obstructive
|
[NCBI]
|
0.000425128
|
|
|
myoclonic epilepsy, juvenile, 3
|
[NCBI]
|
0.000425128
|
|
|
alzheimer disease 8
|
[NCBI]
|
0.000425128
|
|
|
ANON1
|
[NCBI]
|
0.000425128
|
|
|
MCOPS1
|
[NCBI]
|
0.000425128
|
|
|
cholesterol level quantitative trait locus 1
|
[NCBI]
|
0.000401892
|
|
|
stature quantitative trait locus 6
|
[NCBI]
|
0.000401892
|
|
|
DYX3
|
[NCBI]
|
0.000401892
|
|
|
MPD2
|
[NCBI]
|
0.000401892
|
|
|
stature quantitative trait locus 3
|
[NCBI]
|
0.000401892
|
|
|
autoimmune thyroid disease, susceptibility to, 1
|
[NCBI]
|
0.000401892
|
|
|
migraine with or without aura, susceptibility to, 6
|
[NCBI]
|
0.000401892
|
|
|
sclerotylosis
|
[NCBI]
|
0.000401892
|
|
|
HHC3
|
[NCBI]
|
0.000401892
|
|
|
epilepsy, nocturnal frontal lobe, type 2
|
[NCBI]
|
0.000401892
|
|
|
hypobetalipoproteinemia, familial, 2
|
[NCBI]
|
0.000401892
|
|
|
CTAA2
|
[NCBI]
|
0.000401892
|
|
|
EVR3
|
[NCBI]
|
0.000401892
|
|
|
OB10P
|
[NCBI]
|
0.000401892
|
|
|
amyotrophy, neurogenic scapuloperoneal, new england type
|
[NCBI]
|
0.000401892
|
|
|
BRCA3
|
[NCBI]
|
0.000401892
|
|
|
HPC1
|
[NCBI]
|
0.00039571
|
|
|
SCZD7
|
[NCBI]
|
0.000361137
|
|
|
IGES
|
[NCBI]
|
0.000361137
|
|
|
MG
|
[NCBI]
|
0.000348046
|
|
|
IGER
|
[NCBI]
|
0.000340735
|
|
|
SPG3A
|
[NCBI]
|
0.000328337
|
|
|
IBD1
|
[NCBI]
|
0.000322456
|
|
|
SPG6
|
[NCBI]
|
0.000320771
|
|
|
SCZD
|
[NCBI]
|
0.00031937
|
|
|
MDD
|
[NCBI]
|
0.000319273
|
|
|
prostate cancer
|
[NCBI]
|
0.000310137
|
|
|
CELIAC2
|
[NCBI]
|
0.000308008
|
|
|
syndactyly, type i
|
[NCBI]
|
0.000308008
|
|
|
OPA4
|
[NCBI]
|
0.000308008
|
|
|
ETM2
|
[NCBI]
|
0.000308008
|
|
|
AUTS5
|
[NCBI]
|
0.000308008
|
|
|
AD14
|
[NCBI]
|
0.000308008
|
|
|
malignant hyperthermia, susceptibility to, 2
|
[NCBI]
|
0.000308008
|
|
|
CMD1B
|
[NCBI]
|
0.000308008
|
|
|
CORD7
|
[NCBI]
|
0.000308008
|
|
|
IBD3
|
[NCBI]
|
0.000308008
|
|
|
electroencephalogram, low-voltage
|
[NCBI]
|
0.000308008
|
|
|
leptin, serum levels of
|
[NCBI]
|
0.000308008
|
|
|
OFC3
|
[NCBI]
|
0.000308008
|
|
|
AD13
|
[NCBI]
|
0.000308008
|
|
|
BULN1
|
[NCBI]
|
0.000307884
|
|
|
hypertelorism with esophageal abnormality and hypospadias
|
[NCBI]
|
0.000299124
|
|
|
CMT2A1
|
[NCBI]
|
0.000293662
|
|
|
VWS
|
[NCBI]
|
0.000283893
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.000283076
|
|
|
SPG4
|
[NCBI]
|
0.000266391
|
|
|
OTSC1
|
[NCBI]
|
0.000262894
|
|
|
alzheimer disease 6
|
[NCBI]
|
0.000262894
|
|
|
PSORS1
|
[NCBI]
|
0.000259684
|
|
|
FHM1
|
[NCBI]
|
0.000247567
|
|
|
EA2
|
[NCBI]
|
0.000245893
|
|
|
FHM2
|
[NCBI]
|
0.000245893
|
|
|
CMT2A2
|
[NCBI]
|
0.000242708
|
|
|
EKD2
|
[NCBI]
|
0.000240612
|
|
|
ehlers-danlos syndrome, type viii
|
[NCBI]
|
0.000240612
|
|
|
blood group--lutheran inhibitor
|
[NCBI]
|
0.000240612
|
|
|
systemic lupus erythematosus, susceptibility to, 6
|
[NCBI]
|
0.000240612
|
|
|
CNC2
|
[NCBI]
|
0.000240612
|
|
|
SLEB2
|
[NCBI]
|
0.00023524
|
|
|
CMT2B
|
[NCBI]
|
0.000231667
|
|
|
ETM1
|
[NCBI]
|
0.000224935
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
0.000207772
|
|
|
CMM2
|
[NCBI]
|
0.000207464
|
|
|
obesity
|
[NCBI]
|
0.000207174
|
|
|
SCZD4
|
[NCBI]
|
0.00020488
|
|
|
prostate cancer/brain cancer susceptibility
|
[NCBI]
|
0.000204198
|
|
|
MCKD2
|
[NCBI]
|
0.000204198
|
|
|
AITD3
|
[NCBI]
|
0.000204198
|
|
|
neuropathy, hereditary sensory and autonomic, type i, with cough and gastroesophageal reflux
|
[NCBI]
|
0.000200852
|
|
|
EA3
|
[NCBI]
|
0.000200852
|
|
|
CMD1H
|
[NCBI]
|
0.000200852
|
|
|
testicular germ cell tumor 1
|
[NCBI]
|
0.000200852
|
|
|
DFNB33
|
[NCBI]
|
0.000200852
|
|
|
necrotizing encephalopathy, acute, autosomal dominant
|
[NCBI]
|
0.000200852
|
|
|
hepatic fibrosis, severe, susceptibility to, due to schistosoma mansoni infection
|
[NCBI]
|
0.000200852
|
|
|
lentiginosis, inherited patterned
|
[NCBI]
|
0.000200852
|
|
|
HCFP2
|
[NCBI]
|
0.000200852
|
|
|
CMD1K
|
[NCBI]
|
0.000200852
|
|
|
psoriasis susceptibility 6
|
[NCBI]
|
0.000200852
|
|
|
myasthenia, familial infantile, 1
|
[NCBI]
|
0.000200852
|
|
|
SCA25
|
[NCBI]
|
0.000200852
|
|
|
WS2B
|
[NCBI]
|
0.000200852
|
|
|
STUT2
|
[NCBI]
|
0.000200852
|
|
|
glucocorticoid deficiency 3
|
[NCBI]
|
0.000200852
|
|
|
CMT2G
|
[NCBI]
|
0.000200852
|
|
|
DYT13
|
[NCBI]
|
0.000200852
|
|
|
thyroid carcinoma, nonmedullary 1
|
[NCBI]
|
0.000200852
|
|
|
AIS3
|
[NCBI]
|
0.000200852
|
|
|
SPAX1
|
[NCBI]
|
0.000200852
|
|
|
LGMD1F
|
[NCBI]
|
0.000200852
|
|
|
SPG14
|
[NCBI]
|
0.000200852
|
|
|
DFNA18
|
[NCBI]
|
0.000200852
|
|
|
cone-rod dystrophy and amelogenesis imperfecta
|
[NCBI]
|
0.000200852
|
|
|
terminal osseous dysplasia and pigmentary defects
|
[NCBI]
|
0.000200852
|
|
|
LGMD2L
|
[NCBI]
|
0.000200852
|
|
|
ATOD5
|
[NCBI]
|
0.000200852
|
|
|
BMND5
|
[NCBI]
|
0.000200852
|
|
|
hyperaldosteronism, familial, type ii
|
[NCBI]
|
0.000200852
|
|
|
MCOPCB2
|
[NCBI]
|
0.000200852
|
|
|
prostate cancer, hereditary, 9
|
[NCBI]
|
0.000200852
|
|
|
CELIAC5
|
[NCBI]
|
0.000200852
|
|
|
MAFD4
|
[NCBI]
|
0.000200852
|
|
|
brachydactyly, type a1, b
|
[NCBI]
|
0.000200852
|
|
|
NEM6
|
[NCBI]
|
0.000200852
|
|
|
VMD1
|
[NCBI]
|
0.000200852
|
|
|
HDL3
|
[NCBI]
|
0.000200852
|
|
|
basal ganglia calcification, idiopathic, 2
|
[NCBI]
|
0.000200852
|
|
|
MRT12
|
[NCBI]
|
0.000200852
|
|
|
ptosis, hereditary congenital 2
|
[NCBI]
|
0.000200852
|
|
|
PTLAH
|
[NCBI]
|
0.000200852
|
|
|
DFNA7
|
[NCBI]
|
0.000200852
|
|
|
NNCI
|
[NCBI]
|
0.000200852
|
|
|
prostate cancer, hereditary, 6
|
[NCBI]
|
0.000200852
|
|
|
SCA21
|
[NCBI]
|
0.000200852
|
|
|
orthostatic hypotensive disorder, streeten type
|
[NCBI]
|
0.000200852
|
|
|
kala-azar, susceptibility to, 3
|
[NCBI]
|
0.000200852
|
|
|
MPD3
|
[NCBI]
|
0.000200852
|
|
|
cdags syndrome
|
[NCBI]
|
0.000200852
|
|
|
ataxia, sensory, autosomal dominant
|
[NCBI]
|
0.000200852
|
|
|
fasting glucose and specific insulin levels
|
[NCBI]
|
0.000200852
|
|
|
IBD4
|
[NCBI]
|
0.000200852
|
|
|
aortic aneurysm, familial thoracic 2
|
[NCBI]
|
0.000200852
|
|
|
hypertension, essential, susceptibility to, 2
|
[NCBI]
|
0.000200852
|
|
|
ENUR2
|
[NCBI]
|
0.000200852
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal dominant, with thyroid disease
|
[NCBI]
|
0.000200852
|
|
|
AIS2
|
[NCBI]
|
0.000200852
|
|
|
RCM2
|
[NCBI]
|
0.000200852
|
|
|
IDDM6
|
[NCBI]
|
0.000200852
|
|
|
NYS4
|
[NCBI]
|
0.000200852
|
|
|
epilepsy, myoclonic, benign adult familial, type 2
|
[NCBI]
|
0.000200852
|
|
|
epilepsy, partial, with variable foci
|
[NCBI]
|
0.000200852
|
|
|
DYX8
|
[NCBI]
|
0.000200852
|
|
|
MACOM
|
[NCBI]
|
0.000200852
|
|
|
myopia 4
|
[NCBI]
|
0.000200852
|
|
|
kala-azar, susceptibility to, 2
|
[NCBI]
|
0.000200852
|
|
|
ENUR1
|
[NCBI]
|
0.000200852
|
|
|
dermatoglyphics--fingerprint pattern
|
[NCBI]
|
0.000200852
|
|
|
leber congenital amaurosis, type ix
|
[NCBI]
|
0.000200852
|
|
|
aneurysm, intracranial berry, 3
|
[NCBI]
|
0.000200852
|
|
|
AUTS8
|
[NCBI]
|
0.000200852
|
|
|
attention deficit-hyperactivity disorder, susceptibility to, 2
|
[NCBI]
|
0.000200852
|
|
|
MRXS7
|
[NCBI]
|
0.000200852
|
|
|
parkinsonism, early-onset, with mental retardation
|
[NCBI]
|
0.000200852
|
|
|
retinal cone dystrophy 2
|
[NCBI]
|
0.000200852
|
|
|
GLC1A
|
[NCBI]
|
0.000197868
|
|
|
HNFJ
|
[NCBI]
|
0.000197265
|
|
|
EGF
|
[NCBI]
|
0.000194421
|
|
|
MODY
|
[NCBI]
|
0.00019346
|
|
|
VEGF
|
[NCBI]
|
0.000191642
|
|
|
renal failure, progressive, with hypertension
|
[NCBI]
|
0.000189524
|
|
|
BMND3
|
[NCBI]
|
0.000189524
|
|
|
schistosoma mansoni infection, susceptibility/resistance to
|
[NCBI]
|
0.000189524
|
|
|
hodgkin disease, x-linked pseudoautosomal
|
[NCBI]
|
0.000189524
|
|
|
neuropathy, hereditary motor and sensory, russe type
|
[NCBI]
|
0.000189524
|
|
|
CFEOM3
|
[NCBI]
|
0.000189524
|
|
|
mental health wellness 1
|
[NCBI]
|
0.000189524
|
|
|
MEAX
|
[NCBI]
|
0.000189524
|
|
|
PSORS4
|
[NCBI]
|
0.000189524
|
|
|
MNG1
|
[NCBI]
|
0.000189524
|
|
|
graves disease
|
[NCBI]
|
0.000179508
|
|
|
NPHP1
|
[NCBI]
|
0.000178391
|
|
|
NIDDM
|
[NCBI]
|
0.000174036
|
|
|
RP11
|
[NCBI]
|
0.000172048
|
|
|
SCZD2
|
[NCBI]
|
0.000172048
|
|
|
CCZS
|
[NCBI]
|
0.000168629
|
|
|
CTPP3
|
[NCBI]
|
0.000168629
|
|
|
SCZD8
|
[NCBI]
|
0.000168629
|
|
|
MRX54
|
[NCBI]
|
0.000168629
|
|
|
asthma-related traits, susceptibility to, 5
|
[NCBI]
|
0.000168629
|
|
|
BRCA1
|
[NCBI]
|
0.000167836
|
|
|
DFNA6
|
[NCBI]
|
0.000163879
|
|
|
MYP2
|
[NCBI]
|
0.000162733
|
|
|
CMT1A
|
[NCBI]
|
0.000162551
|
|
|
FA
|
[NCBI]
|
0.000159522
|
|
|
hypertension, essential
|
[NCBI]
|
0.000158261
|
|
|
TNF
|
[NCBI]
|
0.000157144
|
|
|
spondyloepimetaphyseal dysplasia, type ii
|
[NCBI]
|
0.000156813
|
|
|
CCA3
|
[NCBI]
|
0.000156813
|
|
|
RP2
|
[NCBI]
|
0.000155527
|
|
|
DFNB10
|
[NCBI]
|
0.000153129
|
|
|
DFNB8
|
[NCBI]
|
0.000153129
|
|
|
SPG13
|
[NCBI]
|
0.000153129
|
|
|
SCA2
|
[NCBI]
|
0.000150142
|
|
|
JME
|
[NCBI]
|
0.000149908
|
|
|
DFN2
|
[NCBI]
|
0.000149536
|
|
|
IDDM7
|
[NCBI]
|
0.000149536
|
|
|
LGMD2B
|
[NCBI]
|
0.000143841
|
|
|
DFNB1
|
[NCBI]
|
0.000141804
|
|
|
SCA5
|
[NCBI]
|
0.000141081
|
|
|
CZP3
|
[NCBI]
|
0.000141081
|
|
|
DURS1
|
[NCBI]
|
0.000137826
|
|
|
twinning, dizygotic
|
[NCBI]
|
0.000137826
|
|
|
PAND1
|
[NCBI]
|
0.000137826
|
|
|
EKD1
|
[NCBI]
|
0.000135548
|
|
|
DHRD
|
[NCBI]
|
0.0001331
|
|
|
acromegaly
|
[NCBI]
|
0.0001331
|
|
|
SCZD1
|
[NCBI]
|
0.0001331
|
|
|
DYX2
|
[NCBI]
|
0.0001331
|
|
|
RP3
|
[NCBI]
|
0.000131407
|
|
|
MEN2A
|
[NCBI]
|
0.000131341
|
|
|
RP10
|
[NCBI]
|
0.000131224
|
|
|
SCA6
|
[NCBI]
|
0.000129864
|
|
|
LGMD2C
|
[NCBI]
|
0.000128222
|
|
|
HNA
|
[NCBI]
|
0.000123823
|
|
|
lipomatosis, multiple
|
[NCBI]
|
0.00012357
|
|
|
hypoalphalipoproteinemia, primary
|
[NCBI]
|
0.00012289
|
|
|
SPG11
|
[NCBI]
|
0.00012289
|
|
|
SPG10
|
[NCBI]
|
0.00012289
|
|
|
HMN2A
|
[NCBI]
|
0.00012289
|
|
|
NPHP3
|
[NCBI]
|
0.00012289
|
|
|
CMT2D
|
[NCBI]
|
0.00012289
|
|
|
PKD2
|
[NCBI]
|
0.00012265
|
|
|
IDDM17
|
[NCBI]
|
0.000120233
|
|
|
persistent hyperplastic primary vitreous, autosomal recessive
|
[NCBI]
|
0.000120233
|
|
|
pyle disease
|
[NCBI]
|
0.000120233
|
|
|
MRX2
|
[NCBI]
|
0.000120233
|
|
|
telangiectasia, hereditary benign
|
[NCBI]
|
0.000120233
|
|
|
MHAC
|
[NCBI]
|
0.000120233
|
|
|
neuropathy, hereditary motor and sensory, okinawa type
|
[NCBI]
|
0.000120233
|
|
|
diaphyseal medullary stenosis with malignant fibrous histiocytoma
|
[NCBI]
|
0.000120233
|
|
|
cerebellar atrophy with progressive microcephaly
|
[NCBI]
|
0.000120233
|
|
|
OPA2
|
[NCBI]
|
0.000120233
|
|
|
ATFB1
|
[NCBI]
|
0.000120233
|
|
|
laterality defects, autosomal dominant
|
[NCBI]
|
0.000120233
|
|
|
auditory neuropathy, autosomal dominant, 1
|
[NCBI]
|
0.000120233
|
|
|
vitreoretinal degeneration, snowflake type
|
[NCBI]
|
0.000120233
|
|
|
MRX20
|
[NCBI]
|
0.000120233
|
|
|
cowchock syndrome
|
[NCBI]
|
0.000120233
|
|
|
CMTX3
|
[NCBI]
|
0.000120233
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal recessive
|
[NCBI]
|
0.000120233
|
|
|
ALSFTD2
|
[NCBI]
|
0.000120233
|
|
|
CND
|
[NCBI]
|
0.000120233
|
|
|
autoimmune thyroid disease, susceptibility to, 2
|
[NCBI]
|
0.000120233
|
|
|
IDDM18
|
[NCBI]
|
0.000120233
|
|
|
branchiootic syndrome 2
|
[NCBI]
|
0.000120233
|
|
|
SCAR6
|
[NCBI]
|
0.000120233
|
|
|
auditory neuropathy, x-linked, 1, with peripheral sensory neuropathy
|
[NCBI]
|
0.000120233
|
|
|
LI5
|
[NCBI]
|
0.000120233
|
|
|
HHC2
|
[NCBI]
|
0.000120233
|
|
|
asthma-related traits, susceptibility to, 6
|
[NCBI]
|
0.000120233
|
|
|
PDR
|
[NCBI]
|
0.000120233
|
|
|
leprosy, susceptibility to, 1
|
[NCBI]
|
0.000120233
|
|
|
split-hand/foot malformation with sensorineural hearing loss
|
[NCBI]
|
0.000120233
|
|
|
DYT15
|
[NCBI]
|
0.000120233
|
|
|
aortic aneurysm, familial thoracic 1
|
[NCBI]
|
0.000120233
|
|
|
AUTS10
|
[NCBI]
|
0.000120233
|
|
|
SPG19
|
[NCBI]
|
0.000120233
|
|
|
CVD1
|
[NCBI]
|
0.000120233
|
|
|
ORW3
|
[NCBI]
|
0.000120233
|
|
|
GLC1M
|
[NCBI]
|
0.000120233
|
|
|
preauricular fistulae, congenital
|
[NCBI]
|
0.000120233
|
|
|
PEE1
|
[NCBI]
|
0.000119973
|
|
|
HEPOD
|
[NCBI]
|
0.000119626
|
|
|
PEE4
|
[NCBI]
|
0.00011896
|
|
|
ARMD10
|
[NCBI]
|
0.00011896
|
|
|
tuberous sclerosis 4
|
[NCBI]
|
0.00011896
|
|
|
CMD3A
|
[NCBI]
|
0.00011896
|
|
|
HMERF
|
[NCBI]
|
0.00011896
|
|
|
BOS3
|
[NCBI]
|
0.00011896
|
|
|
DDU
|
[NCBI]
|
0.00011896
|
|
|
hypertension with brachydactyly
|
[NCBI]
|
0.000117608
|
|
|
SCZD6
|
[NCBI]
|
0.000117608
|
|
|
BFSP2
|
[NCBI]
|
0.000116648
|
|
|
MFN2
|
[NCBI]
|
0.000116465
|
|
|
PKD3
|
[NCBI]
|
0.00011568
|
|
|
SPG17
|
[NCBI]
|
0.00011568
|
|
|
NHS
|
[NCBI]
|
0.000115679
|
|
|
HSAN1
|
[NCBI]
|
0.000115679
|
|
|
PWS
|
[NCBI]
|
0.000112123
|
|
|
DFNA12
|
[NCBI]
|
0.000109335
|
|
|
ARX
|
[NCBI]
|
0.000109233
|
|
|
HYPP
|
[NCBI]
|
0.000108998
|
|
|
USH2A
|
[NCBI]
|
0.000108439
|
|
|
ARMD1
|
[NCBI]
|
0.00010688
|
|
|
POAG
|
[NCBI]
|
0.000104305
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
0.000104305
|
|
|
LAH
|
[NCBI]
|
0.000102073
|
|
|
CFEOM2
|
[NCBI]
|
0.000102073
|
|
|
retinitis pigmentosa-deafness syndrome
|
[NCBI]
|
0.000102073
|
|
|
SCA15
|
[NCBI]
|
0.000102073
|
|
|
coronary heart disease, susceptibility to, 5
|
[NCBI]
|
0.000102073
|
|
|
CELIAC4
|
[NCBI]
|
0.000102073
|
|
|
CMD1C
|
[NCBI]
|
0.000102073
|
|
|
AIS1
|
[NCBI]
|
0.000102073
|
|
|
cataract, autosomal dominant, multiple types 1
|
[NCBI]
|
0.000102073
|
|
|
DPR
|
[NCBI]
|
0.000102073
|
|
|
platelet disorder, familial, with associated myeloid malignancy
|
[NCBI]
|
0.000102073
|
|
|
SCA13
|
[NCBI]
|
0.000102073
|
|
|
EBN2
|
[NCBI]
|
0.000102073
|
|
|
CMT1C
|
[NCBI]
|
0.000102073
|
|
|
PDB
|
[NCBI]
|
0.000101935
|
|
|
CPX
|
[NCBI]
|
0.000101935
|
|
|
central core disease of muscle
|
[NCBI]
|
0.000101935
|
|
|
GDI1
|
[NCBI]
|
0.000100152
|
|
|
osteoarthritis
|
[NCBI]
|
9.89193e-05
|
|
|
ARH
|
[NCBI]
|
9.85792e-05
|
|
|
EIG
|
[NCBI]
|
9.53017e-05
|
|
|
CORDX1
|
[NCBI]
|
9.39449e-05
|
|
|
USH1C
|
[NCBI]
|
9.39449e-05
|
|
|
CFEOM1
|
[NCBI]
|
9.39449e-05
|
|
|
BHD
|
[NCBI]
|
9.39449e-05
|
|
|
trichodentoosseous syndrome
|
[NCBI]
|
9.39449e-05
|
|
|
SPDA1
|
[NCBI]
|
9.32979e-05
|
|
|
DAR
|
[NCBI]
|
9.32979e-05
|
|
|
migraine with or without aura, susceptibility to, 1
|
[NCBI]
|
9.30063e-05
|
|
|
PRL
|
[NCBI]
|
9.20909e-05
|
|
|
AMCN
|
[NCBI]
|
9.18068e-05
|
|
|
dermatitis, atopic
|
[NCBI]
|
9.18068e-05
|
|
|
CRYAA
|
[NCBI]
|
9.10123e-05
|
|
|
alzheimer disease 3
|
[NCBI]
|
9.06711e-05
|
|
|
RP7
|
[NCBI]
|
9.06065e-05
|
|
|
NPHP4
|
[NCBI]
|
9.06065e-05
|
|
|
AH
|
[NCBI]
|
9.06065e-05
|
|
|
HCHOLA3
|
[NCBI]
|
9.06065e-05
|
|
|
seizures, benign familial neonatal-infantile
|
[NCBI]
|
9.06065e-05
|
|
|
DFNB12
|
[NCBI]
|
9.06065e-05
|
|
|
asthma-related traits, susceptibility to, 1
|
[NCBI]
|
9.06065e-05
|
|
|
GDD
|
[NCBI]
|
9.06065e-05
|
|
|
DFNB6
|
[NCBI]
|
9.06065e-05
|
|
|
trismus-pseudocamptodactyly syndrome
|
[NCBI]
|
9.06065e-05
|
|
|
CMT1B
|
[NCBI]
|
8.99619e-05
|
|
|
NGFB
|
[NCBI]
|
8.98746e-05
|
|
|
BHC
|
[NCBI]
|
8.97021e-05
|
|
|
ADLTE
|
[NCBI]
|
8.97021e-05
|
|
|
myotonia congenita, autosomal dominant
|
[NCBI]
|
8.97021e-05
|
|
|
JH
|
[NCBI]
|
8.97021e-05
|
|
|
diabetes mellitus, transient neonatal, 1
|
[NCBI]
|
8.88824e-05
|
|
|
APC
|
[NCBI]
|
8.87589e-05
|
|
|
PGP
|
[NCBI]
|
8.85159e-05
|
|
|
PCOS1
|
[NCBI]
|
8.75289e-05
|
|
|
CMDD
|
[NCBI]
|
8.57942e-05
|
|
|
exostoses, multiple, type ii
|
[NCBI]
|
8.57942e-05
|
|
|
SCA1
|
[NCBI]
|
8.38309e-05
|
|
|
infantile spasm syndrome, x-linked
|
[NCBI]
|
8.2176e-05
|
|
|
hydatidiform mole
|
[NCBI]
|
8.2176e-05
|
|
|
SPCH1
|
[NCBI]
|
8.2176e-05
|
|
|
AHDS
|
[NCBI]
|
8.2176e-05
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
8.2176e-05
|
|
|
SPG2
|
[NCBI]
|
8.2176e-05
|
|
|
RP13
|
[NCBI]
|
8.19142e-05
|
|
|
DFNA20
|
[NCBI]
|
8.19142e-05
|
|
|
CMD1E
|
[NCBI]
|
8.19142e-05
|
|
|
HOMG2
|
[NCBI]
|
8.19142e-05
|
|
|
cherubism
|
[NCBI]
|
8.19142e-05
|
|
|
PARK2
|
[NCBI]
|
8.1196e-05
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
7.88108e-05
|
|
|
EAOH
|
[NCBI]
|
7.88108e-05
|
|
|
SPG3A
|
[NCBI]
|
7.87178e-05
|
|
|
CISS1
|
[NCBI]
|
7.83995e-05
|
|
|
platyspondyly with amelogenesis imperfecta
|
[NCBI]
|
7.83995e-05
|
|
|
HHF5
|
[NCBI]
|
7.83995e-05
|
|
|
NEM5
|
[NCBI]
|
7.83995e-05
|
|
|
TSC3
|
[NCBI]
|
7.83995e-05
|
|
|
CATCN2
|
[NCBI]
|
7.83995e-05
|
|
|
DFNB23
|
[NCBI]
|
7.83995e-05
|
|
|
oligodontia-colorectal cancer syndrome
|
[NCBI]
|
7.83995e-05
|
|
|
MRX14
|
[NCBI]
|
7.83995e-05
|
|
|
ATFB3
|
[NCBI]
|
7.83995e-05
|
|
|
CMH2
|
[NCBI]
|
7.83995e-05
|
|
|
epilepsy, benign neonatal, autosomal recessive
|
[NCBI]
|
7.83995e-05
|
|
|
ROCA
|
[NCBI]
|
7.83995e-05
|
|
|
hearing loss, sensorineural, with enamel hypoplasia and nail defects
|
[NCBI]
|
7.83995e-05
|
|
|
microcephaly with simplified gyral pattern
|
[NCBI]
|
7.83995e-05
|
|
|
BFLS
|
[NCBI]
|
7.56687e-05
|
|
|
EBN1
|
[NCBI]
|
7.56687e-05
|
|
|
GEFS+
|
[NCBI]
|
7.56687e-05
|
|
|
CRYBA1
|
[NCBI]
|
7.55673e-05
|
|
|
ALD
|
[NCBI]
|
7.51356e-05
|
|
|
CLN3
|
[NCBI]
|
7.49944e-05
|
|
|
CMTX1
|
[NCBI]
|
7.49944e-05
|
|
|
RP9
|
[NCBI]
|
7.49292e-05
|
|
|
charcot-marie-tooth disease, dominant intermediate b
|
[NCBI]
|
7.49292e-05
|
|
|
STHAG3
|
[NCBI]
|
7.49292e-05
|
|
|
EJM1
|
[NCBI]
|
7.49292e-05
|
|
|
body mass index
|
[NCBI]
|
7.49292e-05
|
|
|
DSAP1
|
[NCBI]
|
7.49292e-05
|
|
|
mental health wellness 2
|
[NCBI]
|
7.49292e-05
|
|
|
CCA2
|
[NCBI]
|
7.49292e-05
|
|
|
naegeli syndrome
|
[NCBI]
|
7.49292e-05
|
|
|
IDDM5
|
[NCBI]
|
7.49292e-05
|
|
|
ARMD7
|
[NCBI]
|
7.49292e-05
|
|
|
HMPS1
|
[NCBI]
|
7.47133e-05
|
|
|
keratolytic winter erythema
|
[NCBI]
|
7.47133e-05
|
|
|
EXT3
|
[NCBI]
|
7.47133e-05
|
|
|
spinal muscular atrophy, distal, congenital nonprogressive
|
[NCBI]
|
7.47133e-05
|
|
|
CCV
|
[NCBI]
|
7.47133e-05
|
|
|
opioid dependence, susceptibility to, 1
|
[NCBI]
|
7.47133e-05
|
|
|
endometriosis, susceptibility to, 1
|
[NCBI]
|
7.47133e-05
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal dominant
|
[NCBI]
|
7.47133e-05
|
|
|
arrhythmogenic right ventricular dysplasia, familial, 6
|
[NCBI]
|
7.47133e-05
|
|
|
gout susceptibility 1
|
[NCBI]
|
7.47133e-05
|
|
|
CMT2B2
|
[NCBI]
|
7.47133e-05
|
|
|
PSNP2
|
[NCBI]
|
7.47133e-05
|
|
|
pulmonary function
|
[NCBI]
|
7.47133e-05
|
|
|
CORD8
|
[NCBI]
|
7.47133e-05
|
|
|
charcot-marie-tooth disease, dominant intermediate a
|
[NCBI]
|
7.47133e-05
|
|
|
eosinophilia, familial
|
[NCBI]
|
7.47133e-05
|
|
|
DFNB15
|
[NCBI]
|
7.47133e-05
|
|
|
otitis media, susceptibility to
|
[NCBI]
|
7.47133e-05
|
|
|
EA4
|
[NCBI]
|
7.47133e-05
|
|
|
DYX5
|
[NCBI]
|
7.47133e-05
|
|
|
ALS5
|
[NCBI]
|
7.47133e-05
|
|
|
ALSFTD1
|
[NCBI]
|
7.47133e-05
|
|
|
dupuytren contracture
|
[NCBI]
|
7.47133e-05
|
|
|
GSM1
|
[NCBI]
|
7.47133e-05
|
|
|
SCA19
|
[NCBI]
|
7.47133e-05
|
|
|
ARVD5
|
[NCBI]
|
7.47133e-05
|
|
|
DYX6
|
[NCBI]
|
7.47133e-05
|
|
|
asthma-related traits, susceptibility to, 3
|
[NCBI]
|
7.47133e-05
|
|
|
PTOS1
|
[NCBI]
|
7.47133e-05
|
|
|
dyschromatosis universalis hereditaria
|
[NCBI]
|
7.47133e-05
|
|
|
kala-azar, susceptibility to, 1
|
[NCBI]
|
7.47133e-05
|
|
|
speech-sound disorder
|
[NCBI]
|
7.47133e-05
|
|
|
HBFQTL4
|
[NCBI]
|
7.47133e-05
|
|
|
muscular dystrophy, congenital, merosin-positive
|
[NCBI]
|
7.47133e-05
|
|
|
CORD5
|
[NCBI]
|
7.47133e-05
|
|
|
MYP1
|
[NCBI]
|
7.47133e-05
|
|
|
autism, susceptibility to, 3
|
[NCBI]
|
7.47133e-05
|
|
|
SCZD5
|
[NCBI]
|
7.47133e-05
|
|
|
nasopharyngeal carcinoma 1
|
[NCBI]
|
7.47133e-05
|
|
|
ARVD4
|
[NCBI]
|
7.47133e-05
|
|
|
CHDM
|
[NCBI]
|
7.47133e-05
|
|
|
NIPA1
|
[NCBI]
|
7.42934e-05
|
|
|
LW
|
[NCBI]
|
7.42934e-05
|
|
|
GJA3
|
[NCBI]
|
7.41407e-05
|
|
|
LQT1
|
[NCBI]
|
7.36709e-05
|
|
|
GUCY2D
|
[NCBI]
|
7.27977e-05
|
|
|
ORW2
|
[NCBI]
|
7.27247e-05
|
|
|
PMC
|
[NCBI]
|
7.27247e-05
|
|
|
WDM
|
[NCBI]
|
7.08217e-05
|
|
|
IBD5
|
[NCBI]
|
7.08217e-05
|
|
|
epilepsy, myoclonic, benign adult familial, type 1
|
[NCBI]
|
7.08217e-05
|
|
|
NPHP2
|
[NCBI]
|
6.91065e-05
|
|
|
opitz syndrome
|
[NCBI]
|
6.91065e-05
|
|
|
KCS
|
[NCBI]
|
6.91065e-05
|
|
|
vitiligo
|
[NCBI]
|
6.91065e-05
|
|
|
HRD
|
[NCBI]
|
6.91065e-05
|
|
|
epilepsy, nocturnal frontal lobe, type 1
|
[NCBI]
|
6.91065e-05
|
|
|
AMDM
|
[NCBI]
|
6.91065e-05
|
|
|
WFS1
|
[NCBI]
|
6.80989e-05
|
|
|
BTK
|
[NCBI]
|
6.80249e-05
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
6.76176e-05
|
|
|
TM4SF2
|
[NCBI]
|
6.75956e-05
|
|
|
KIF1B
|
[NCBI]
|
6.75956e-05
|
|
|
CNC1
|
[NCBI]
|
6.73498e-05
|
|
|
deafness, conductive, with stapes fixation
|
[NCBI]
|
6.73498e-05
|
|
|
CDH23
|
[NCBI]
|
6.70614e-05
|
|
|
DISC2
|
[NCBI]
|
6.59715e-05
|
|
|
OFC1
|
[NCBI]
|
6.54696e-05
|
|
|
KLK3
|
[NCBI]
|
6.52192e-05
|
|
|
CSNB1A
|
[NCBI]
|
6.4886e-05
|
|
|
TGD
|
[NCBI]
|
6.4886e-05
|
|
|
autism
|
[NCBI]
|
6.44579e-05
|
|
|
IDDM
|
[NCBI]
|
6.43334e-05
|
|
|
CRYAB
|
[NCBI]
|
6.42069e-05
|
|
|
NIDDM1
|
[NCBI]
|
6.41276e-05
|
|
|
tobacco addiction, susceptibility to
|
[NCBI]
|
6.41276e-05
|
|
|
hyperlipidemia, combined, 1
|
[NCBI]
|
6.41276e-05
|
|
|
RP12
|
[NCBI]
|
6.41276e-05
|
|
|
ADHR
|
[NCBI]
|
6.41276e-05
|
|
|
SCA12
|
[NCBI]
|
6.41276e-05
|
|
|
NPY
|
[NCBI]
|
6.29958e-05
|
|
|
JPS
|
[NCBI]
|
6.28016e-05
|
|
|
LMBR1
|
[NCBI]
|
6.27866e-05
|
|
|
ANKH
|
[NCBI]
|
6.27866e-05
|
|
|
ACHE
|
[NCBI]
|
6.14985e-05
|
|
|
MDM1
|
[NCBI]
|
6.08058e-05
|
|
|
MHA
|
[NCBI]
|
6.03393e-05
|
|
|
thiourea tasting
|
[NCBI]
|
6.03393e-05
|
|
|
PNKD1
|
[NCBI]
|
6.03393e-05
|
|
|
alzheimer disease 4
|
[NCBI]
|
5.97899e-05
|
|
|
lymphedema, hereditary, i
|
[NCBI]
|
5.97899e-05
|
|
|
corneal dystrophy, gelatinous drop-like
|
[NCBI]
|
5.97899e-05
|
|
|
DFNB9
|
[NCBI]
|
5.97899e-05
|
|
|
MCPH5
|
[NCBI]
|
5.97899e-05
|
|
|
USH1D
|
[NCBI]
|
5.97899e-05
|
|
|
DA1
|
[NCBI]
|
5.97899e-05
|
|
|
DFNA2
|
[NCBI]
|
5.97899e-05
|
|
|
PITX3
|
[NCBI]
|
5.90291e-05
|
|
|
loc387715 gene
|
[NCBI]
|
5.90291e-05
|
|
|
DYX1
|
[NCBI]
|
5.82351e-05
|
|
|
dyschromatosis symmetrica hereditaria 1
|
[NCBI]
|
5.82351e-05
|
|
|
SMA2
|
[NCBI]
|
5.82351e-05
|
|
|
chiari malformation type i
|
[NCBI]
|
5.76526e-05
|
|
|
MCDR1
|
[NCBI]
|
5.76526e-05
|
|
|
JBTS1
|
[NCBI]
|
5.76526e-05
|
|
|
CRYGC
|
[NCBI]
|
5.74185e-05
|
|
|
SEPT9
|
[NCBI]
|
5.74185e-05
|
|
|
AD
|
[NCBI]
|
5.69929e-05
|
|
|
MYO7A
|
[NCBI]
|
5.66837e-05
|
|
|
MODY3
|
[NCBI]
|
5.59563e-05
|
|
|
HNPCC2
|
[NCBI]
|
5.59563e-05
|
|
|
DGI1
|
[NCBI]
|
5.59563e-05
|
|
|
SLSN1
|
[NCBI]
|
5.59563e-05
|
|
|
BDA1
|
[NCBI]
|
5.59563e-05
|
|
|
SCAR1
|
[NCBI]
|
5.59563e-05
|
|
|
GVM
|
[NCBI]
|
5.59563e-05
|
|
|
GINGF
|
[NCBI]
|
5.59563e-05
|
|
|
OCD1
|
[NCBI]
|
5.59563e-05
|
|
|
RYR1
|
[NCBI]
|
5.58058e-05
|
|
|
OPTN
|
[NCBI]
|
5.54423e-05
|
|
|
glutathione s-transferase, omega-1
|
[NCBI]
|
5.46341e-05
|
|
|
PCSK9
|
[NCBI]
|
5.45892e-05
|
|
|
LU
|
[NCBI]
|
5.45892e-05
|
|
|
CRYGD
|
[NCBI]
|
5.45892e-05
|
|
|
BRCA2
|
[NCBI]
|
5.44577e-05
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
5.44244e-05
|
|
|
usher syndrome, type i
|
[NCBI]
|
5.43206e-05
|
|
|
HSAS
|
[NCBI]
|
5.43206e-05
|
|
|
VHL
|
[NCBI]
|
5.37637e-05
|
|
|
TNFRSF11A
|
[NCBI]
|
5.33321e-05
|
|
|
RHO
|
[NCBI]
|
5.3033e-05
|
|
|
MHS1
|
[NCBI]
|
5.29856e-05
|
|
|
MRXS13
|
[NCBI]
|
5.25295e-05
|
|
|
CMT4A
|
[NCBI]
|
5.25295e-05
|
|
|
leiomyoma, hereditary multiple, of skin
|
[NCBI]
|
5.25295e-05
|
|
|
CLN5
|
[NCBI]
|
5.25295e-05
|
|
|
CYLD
|
[NCBI]
|
5.25295e-05
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
5.25295e-05
|
|
|
SACS
|
[NCBI]
|
5.25295e-05
|
|
|
myotonia congenita, autosomal recessive
|
[NCBI]
|
5.25295e-05
|
|
|
HRPT2
|
[NCBI]
|
5.25295e-05
|
|
|
acheiropody
|
[NCBI]
|
5.25295e-05
|
|
|
RP1
|
[NCBI]
|
5.24957e-05
|
|
|
PRNP
|
[NCBI]
|
5.22424e-05
|
|
|
CRYBB2
|
[NCBI]
|
5.2161e-05
|
|
|
SCA7
|
[NCBI]
|
5.17358e-05
|
|
|
EPO
|
[NCBI]
|
5.14366e-05
|
|
|
WFS2
|
[NCBI]
|
5.10297e-05
|
|
|
LOCS
|
[NCBI]
|
5.10297e-05
|
|
|
NFTC
|
[NCBI]
|
5.10297e-05
|
|
|
filaminopathy, autosomal dominant
|
[NCBI]
|
5.10297e-05
|
|
|
CDD
|
[NCBI]
|
5.10297e-05
|
|
|
MKS4
|
[NCBI]
|
5.10297e-05
|
|
|
SLSN4
|
[NCBI]
|
5.10297e-05
|
|
|
retinopathy, pigmentary, and mental retardation
|
[NCBI]
|
5.10297e-05
|
|
|
mast syndrome
|
[NCBI]
|
5.10297e-05
|
|
|
cataract, lamellar 2
|
[NCBI]
|
5.10297e-05
|
|
|
aortic aneurysm, familial thoracic 3
|
[NCBI]
|
5.10297e-05
|
|
|
radial aplasia, x-linked
|
[NCBI]
|
5.10297e-05
|
|
|
malignant hyperthermia, susceptibility to, 5
|
[NCBI]
|
5.10297e-05
|
|
|
ear pits, posterior helical
|
[NCBI]
|
5.10297e-05
|
|
|
LCCS2
|
[NCBI]
|
5.10297e-05
|
|
|
urticaria, familial localized heat
|
[NCBI]
|
5.10297e-05
|
|
|
optic atrophy 3, autosomal dominant
|
[NCBI]
|
5.10297e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2l
|
[NCBI]
|
5.10297e-05
|
|
|
CMT2K
|
[NCBI]
|
5.10297e-05
|
|
|
carney complex variant
|
[NCBI]
|
5.10297e-05
|
|
|
NFRCD
|
[NCBI]
|
5.10297e-05
|
|
|
microphthalmia, isolated, with cataract 4
|
[NCBI]
|
5.10297e-05
|
|
|
XMRE
|
[NCBI]
|
5.10297e-05
|
|
|
cataract, crystalline aculeiform
|
[NCBI]
|
5.10297e-05
|
|
|
CMH8
|
[NCBI]
|
5.10297e-05
|
|
|
CLSD
|
[NCBI]
|
5.10297e-05
|
|
|
SPG5B
|
[NCBI]
|
5.10297e-05
|
|
|
CMH10
|
[NCBI]
|
5.10297e-05
|
|
|
alzheimer disease without neurofibrillary tangles
|
[NCBI]
|
5.10297e-05
|
|
|
SCA16
|
[NCBI]
|
5.10297e-05
|
|
|
DFNA23
|
[NCBI]
|
5.10297e-05
|
|
|
uric acid nephrolithiasis, susceptibility to
|
[NCBI]
|
5.10297e-05
|
|
|
MRX45
|
[NCBI]
|
5.10297e-05
|
|
|
MCPHA
|
[NCBI]
|
5.10297e-05
|
|
|
deafness, autosomal dominant nonsyndromic sensorineural, due to mutation in myo1a
|
[NCBI]
|
5.10297e-05
|
|
|
MCPH3
|
[NCBI]
|
5.10297e-05
|
|
|
MRXS10
|
[NCBI]
|
5.10297e-05
|
|
|
charcot-marie-tooth disease, dominant intermediate c
|
[NCBI]
|
5.10297e-05
|
|
|
EXT2
|
[NCBI]
|
5.00354e-05
|
|
|
FRDA
|
[NCBI]
|
4.97364e-05
|
|
|
NEF3
|
[NCBI]
|
4.95228e-05
|
|
|
alzheimer disease 2
|
[NCBI]
|
4.94381e-05
|
|
|
monilethrix
|
[NCBI]
|
4.94381e-05
|
|
|
BMND1
|
[NCBI]
|
4.94381e-05
|
|
|
ALS2
|
[NCBI]
|
4.94381e-05
|
|
|
ED2
|
[NCBI]
|
4.94381e-05
|
|
|
OPD1
|
[NCBI]
|
4.94381e-05
|
|
|
KFSD
|
[NCBI]
|
4.94381e-05
|
|
|
CMD3B
|
[NCBI]
|
4.94381e-05
|
|
|
wolff-parkinson-white syndrome
|
[NCBI]
|
4.94381e-05
|
|
|
crouzon syndrome
|
[NCBI]
|
4.94381e-05
|
|
|
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 1
|
[NCBI]
|
4.94381e-05
|
|
|
sacral defect with anterior meningocele
|
[NCBI]
|
4.94381e-05
|
|
|
ACTC1
|
[NCBI]
|
4.90646e-05
|
|
|
PTH
|
[NCBI]
|
4.8483e-05
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
4.81945e-05
|
|
|
MJD
|
[NCBI]
|
4.75491e-05
|
|
|
cystinuria
|
[NCBI]
|
4.74781e-05
|
|
|
FCHL
|
[NCBI]
|
4.74781e-05
|
|
|
EA1
|
[NCBI]
|
4.66279e-05
|
|
|
WGN1
|
[NCBI]
|
4.66279e-05
|
|
|
AGS1
|
[NCBI]
|
4.66279e-05
|
|
|
HMN5
|
[NCBI]
|
4.66279e-05
|
|
|
MYOC
|
[NCBI]
|
4.64029e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
4.63217e-05
|
|
|
RTT
|
[NCBI]
|
4.5999e-05
|
|
|
LGMD2A
|
[NCBI]
|
4.59413e-05
|
|
|
PGL1
|
[NCBI]
|
4.59413e-05
|
|
|
FECD2
|
[NCBI]
|
4.58648e-05
|
|
|
GLC1C
|
[NCBI]
|
4.58648e-05
|
|
|
diabetes mellitus, insulin-dependent, x-linked, susceptibility to
|
[NCBI]
|
4.58648e-05
|
|
|
plasmodium falciparum blood infection level
|
[NCBI]
|
4.58648e-05
|
|
|
CTAA1
|
[NCBI]
|
4.58648e-05
|
|
|
larsen syndrome, recessive
|
[NCBI]
|
4.58648e-05
|
|
|
convulsions, benign familial infantile, 1
|
[NCBI]
|
4.58648e-05
|
|
|
EFMR
|
[NCBI]
|
4.58648e-05
|
|
|
acromegaloid facial appearance syndrome
|
[NCBI]
|
4.58648e-05
|
|
|
CMDR
|
[NCBI]
|
4.58648e-05
|
|
|
CTPP1
|
[NCBI]
|
4.58648e-05
|
|
|
molar i reinclusion
|
[NCBI]
|
4.58648e-05
|
|
|
cerebral palsy, ataxic, autosomal recessive
|
[NCBI]
|
4.58648e-05
|
|
|
HBD
|
[NCBI]
|
4.58648e-05
|
|
|
glomerulopathy with fibronectin deposits
|
[NCBI]
|
4.58648e-05
|
|
|
USH2B
|
[NCBI]
|
4.58648e-05
|
|
|
CRH
|
[NCBI]
|
4.56989e-05
|
|
|
APP
|
[NCBI]
|
4.55192e-05
|
|
|
MS
|
[NCBI]
|
4.52836e-05
|
|
|
HSR
|
[NCBI]
|
4.49036e-05
|
|
|
MIP
|
[NCBI]
|
4.41821e-05
|
|
|
SLC3A1
|
[NCBI]
|
4.41821e-05
|
|
|
MCPH1
|
[NCBI]
|
4.40569e-05
|
|
|
SOST
|
[NCBI]
|
4.40569e-05
|
|
|
SCN1A
|
[NCBI]
|
4.34904e-05
|
|
|
GJB2
|
[NCBI]
|
4.34557e-05
|
|
|
NPHP3
|
[NCBI]
|
4.33433e-05
|
|
|
PKD1
|
[NCBI]
|
4.30857e-05
|
|
|
FCAS
|
[NCBI]
|
4.30463e-05
|
|
|
SOD1
|
[NCBI]
|
4.28438e-05
|
|
|
AS
|
[NCBI]
|
4.2785e-05
|
|
|
MAFD6
|
[NCBI]
|
4.26448e-05
|
|
|
GJA8
|
[NCBI]
|
4.21878e-05
|
|
|
PFIC1
|
[NCBI]
|
4.16919e-05
|
|
|
seckel syndrome 1
|
[NCBI]
|
4.16919e-05
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
4.16919e-05
|
|
|
diabetes insipidus, neurohypophyseal type
|
[NCBI]
|
4.16919e-05
|
|
|
IPEX
|
[NCBI]
|
4.16919e-05
|
|
|
MEB
|
[NCBI]
|
4.16811e-05
|
|
|
NOG
|
[NCBI]
|
4.1573e-05
|
|
|
HSPB8
|
[NCBI]
|
4.11724e-05
|
|
|
CHMP4B
|
[NCBI]
|
4.11724e-05
|
|
|
DISC1
|
[NCBI]
|
4.09802e-05
|
|
|
MCPH6
|
[NCBI]
|
4.09508e-05
|
|
|
spastic ataxia
|
[NCBI]
|
4.09508e-05
|
|
|
IAHSP
|
[NCBI]
|
4.09508e-05
|
|
|
MRT3
|
[NCBI]
|
4.09508e-05
|
|
|
SCA11
|
[NCBI]
|
4.09508e-05
|
|
|
epilepsy, nocturnal frontal lobe, type 3
|
[NCBI]
|
4.09508e-05
|
|
|
EDM5
|
[NCBI]
|
4.09508e-05
|
|
|
DFNB31
|
[NCBI]
|
4.09508e-05
|
|
|
urticaria, aquagenic
|
[NCBI]
|
4.09508e-05
|
|
|
ATOD4
|
[NCBI]
|
4.09508e-05
|
|
|
aortic aneurysm, familial thoracic 4
|
[NCBI]
|
4.09508e-05
|
|
|
axenfeld-rieger anomaly with partially absent eye muscles, distinctive face, hydrocephaly, and skeletal abnormalities
|
[NCBI]
|
4.09508e-05
|
|
|
chromosome xp11.3 deletion syndrome
|
[NCBI]
|
4.09508e-05
|
|
|
AI1G
|
[NCBI]
|
4.09508e-05
|
|
|
CMD1P
|
[NCBI]
|
4.09508e-05
|
|
|
meniere disease
|
[NCBI]
|
4.09508e-05
|
|
|
FHM3
|
[NCBI]
|
4.09508e-05
|
|
|
MRX46
|
[NCBI]
|
4.09508e-05
|
|
|
stroke, susceptibility to, 1
|
[NCBI]
|
4.09508e-05
|
|
|
LCA4
|
[NCBI]
|
4.09508e-05
|
|
|
cochleosaccular degeneration of the inner ear with progressive cataracts
|
[NCBI]
|
4.09508e-05
|
|
|
chondrosarcoma
|
[NCBI]
|
4.09508e-05
|
|
|
ACFD
|
[NCBI]
|
4.09508e-05
|
|
|
brunner syndrome
|
[NCBI]
|
4.09508e-05
|
|
|
DFNB16
|
[NCBI]
|
4.09508e-05
|
|
|
diabetes mellitus, permanent neonatal, with cerebellar agenesis
|
[NCBI]
|
4.09508e-05
|
|
|
MRX58
|
[NCBI]
|
4.09508e-05
|
|
|
FEB3
|
[NCBI]
|
4.09508e-05
|
|
|
COD3
|
[NCBI]
|
4.09508e-05
|
|
|
siderius x-linked mental retardation syndrome
|
[NCBI]
|
4.09508e-05
|
|
|
MRGH
|
[NCBI]
|
4.09508e-05
|
|
|
autism, x-linked, susceptibility to, 1
|
[NCBI]
|
4.09508e-05
|
|
|
brugada syndrome 2
|
[NCBI]
|
4.09508e-05
|
|
|
leprosy, susceptibility to, 4
|
[NCBI]
|
4.09508e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2e
|
[NCBI]
|
4.09508e-05
|
|
|
parotid proline-rich salivary protein pc
|
[NCBI]
|
4.09508e-05
|
|
|
neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive
|
[NCBI]
|
4.09508e-05
|
|
|
RP26
|
[NCBI]
|
4.09508e-05
|
|
|
RBP4
|
[NCBI]
|
4.04079e-05
|
|
|
CHH
|
[NCBI]
|
3.9938e-05
|
|
|
FTL
|
[NCBI]
|
3.98549e-05
|
|
|
MTRNR1
|
[NCBI]
|
3.98549e-05
|
|
|
IBGC1
|
[NCBI]
|
3.98312e-05
|
|
|
MRD
|
[NCBI]
|
3.98312e-05
|
|
|
FEB1
|
[NCBI]
|
3.98312e-05
|
|
|
periodontitis, aggressive, 1
|
[NCBI]
|
3.95063e-05
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
3.92993e-05
|
|
|
CDAN2
|
[NCBI]
|
3.92993e-05
|
|
|
HD
|
[NCBI]
|
3.82846e-05
|
|
|
ND
|
[NCBI]
|
3.81165e-05
|
|
|
OA1
|
[NCBI]
|
3.78129e-05
|
|
|
GCKR
|
[NCBI]
|
3.77715e-05
|
|
|
ARHGEF6
|
[NCBI]
|
3.77715e-05
|
|
|
GRIK1
|
[NCBI]
|
3.77715e-05
|
|
|
CD
|
[NCBI]
|
3.73688e-05
|
|
|
ASS
|
[NCBI]
|
3.7367e-05
|
|
|
CCK
|
[NCBI]
|
3.72469e-05
|
|
|
APOC2
|
[NCBI]
|
3.68806e-05
|
|
|
FANCA
|
[NCBI]
|
3.68806e-05
|
|
|
HRPT1
|
[NCBI]
|
3.55892e-05
|
|
|
PCLD
|
[NCBI]
|
3.55892e-05
|
|
|
IBM2
|
[NCBI]
|
3.55892e-05
|
|
|
menkes disease
|
[NCBI]
|
3.55395e-05
|
|
|
MEN1
|
[NCBI]
|
3.51806e-05
|
|
|
SLC17A5
|
[NCBI]
|
3.51517e-05
|
|
|
ALS1
|
[NCBI]
|
3.47192e-05
|
|
|
PRTS
|
[NCBI]
|
3.45472e-05
|
|
|
CORD6
|
[NCBI]
|
3.45472e-05
|
|
|
leprosy, susceptibility to, 2
|
[NCBI]
|
3.45472e-05
|
|
|
VAMAS1
|
[NCBI]
|
3.45472e-05
|
|
|
charcot-marie-tooth disease, axonal, with vocal cord paresis, autosomal recessive
|
[NCBI]
|
3.45472e-05
|
|
|
RP18
|
[NCBI]
|
3.45472e-05
|
|
|
immunodeficiency with hyper-igm, type 2
|
[NCBI]
|
3.45472e-05
|
|
|
XS
|
[NCBI]
|
3.45472e-05
|
|
|
bietti crystalline corneoretinal dystrophy
|
[NCBI]
|
3.45472e-05
|
|
|
MRT2
|
[NCBI]
|
3.45472e-05
|
|
|
allergic rhinitis
|
[NCBI]
|
3.45472e-05
|
|
|
LCA5
|
[NCBI]
|
3.45472e-05
|
|
|
DI
|
[NCBI]
|
3.45472e-05
|
|
|
EEG
|
[NCBI]
|
3.45472e-05
|
|
|
alpha-b crystallinopathy
|
[NCBI]
|
3.45472e-05
|
|
|
bilirubin, elevated concentrations of, in serum
|
[NCBI]
|
3.45472e-05
|
|
|
SPG7
|
[NCBI]
|
3.45472e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 2
|
[NCBI]
|
3.45472e-05
|
|
|
cardiac arrhythmia, ankyrin-b-related
|
[NCBI]
|
3.45472e-05
|
|
|
cardiomyopathy, dilated, autosomal recessive
|
[NCBI]
|
3.45472e-05
|
|
|
FSGS2
|
[NCBI]
|
3.45472e-05
|
|
|
resting heart rate
|
[NCBI]
|
3.45472e-05
|
|
|
ASAT
|
[NCBI]
|
3.45472e-05
|
|
|
leber congenital amaurosis, type iii
|
[NCBI]
|
3.45472e-05
|
|
|
lactase deficiency, congenital
|
[NCBI]
|
3.45472e-05
|
|
|
simpson-golabi-behmel syndrome, type 2
|
[NCBI]
|
3.45472e-05
|
|
|
USH1F
|
[NCBI]
|
3.45472e-05
|
|
|
MRX30
|
[NCBI]
|
3.45472e-05
|
|
|
LI3
|
[NCBI]
|
3.45472e-05
|
|
|
AT
|
[NCBI]
|
3.45285e-05
|
|
|
MLC1
|
[NCBI]
|
3.40374e-05
|
|
|
FLCN
|
[NCBI]
|
3.40374e-05
|
|
|
MS4A2
|
[NCBI]
|
3.40374e-05
|
|
|
AFP
|
[NCBI]
|
3.39778e-05
|
|
|
SCA10
|
[NCBI]
|
3.38246e-05
|
|
|
MSS
|
[NCBI]
|
3.38246e-05
|
|
|
MVP
|
[NCBI]
|
3.37087e-05
|
|
|
PSACH
|
[NCBI]
|
3.31335e-05
|
|
|
SIX1
|
[NCBI]
|
3.30227e-05
|
|
|
KRT24
|
[NCBI]
|
3.29826e-05
|
|
|
GPR85
|
[NCBI]
|
3.29826e-05
|
|
|
PPP2R2C
|
[NCBI]
|
3.29826e-05
|
|
|
obesity, susceptibility to, on chromosome 10q
|
[NCBI]
|
3.29826e-05
|
|
|
SREB3
|
[NCBI]
|
3.29826e-05
|
|
|
radial ray deficiency, x-linked
|
[NCBI]
|
3.29826e-05
|
|
|
transmembrane 7 superfamily, member 3
|
[NCBI]
|
3.29826e-05
|
|
|
BMND8
|
[NCBI]
|
3.29826e-05
|
|
|
HMG20A
|
[NCBI]
|
3.29826e-05
|
|
|
mental retardation, x-linked, with short stature
|
[NCBI]
|
3.29826e-05
|
|
|
GPR27
|
[NCBI]
|
3.29826e-05
|
|
|
NF1
|
[NCBI]
|
3.28214e-05
|
|
|
MBP
|
[NCBI]
|
3.28099e-05
|
|
|
RIEG1
|
[NCBI]
|
3.21715e-05
|
|
|
TPM1
|
[NCBI]
|
3.20915e-05
|
|
|
XG
|
[NCBI]
|
3.20915e-05
|
|
|
alsin
|
[NCBI]
|
3.20915e-05
|
|
|
CACNA1A
|
[NCBI]
|
3.18686e-05
|
|
|
PRH1
|
[NCBI]
|
3.12314e-05
|
|
|
TECTA
|
[NCBI]
|
3.12314e-05
|
|
|
HSPD1
|
[NCBI]
|
3.12314e-05
|
|
|
F13A1
|
[NCBI]
|
3.12217e-05
|
|
|
stomatocytosis i
|
[NCBI]
|
3.10331e-05
|
|
|
donohue syndrome
|
[NCBI]
|
3.06189e-05
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
3.06189e-05
|
|
|
megaloblastic anemia 1
|
[NCBI]
|
3.06189e-05
|
|
|
sialuria, finnish type
|
[NCBI]
|
3.06189e-05
|
|
|
GDAP1
|
[NCBI]
|
3.04324e-05
|
|
|
PFC
|
[NCBI]
|
3.04324e-05
|
|
|
APOA2
|
[NCBI]
|
3.04324e-05
|
|
|
COCH
|
[NCBI]
|
3.04324e-05
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
3.04132e-05
|
|
|
APOB
|
[NCBI]
|
3.02035e-05
|
|
|
CACP
|
[NCBI]
|
2.98892e-05
|
|
|
EDM2
|
[NCBI]
|
2.98892e-05
|
|
|
IDDM10
|
[NCBI]
|
2.98892e-05
|
|
|
vohwinkel syndrome, variant form
|
[NCBI]
|
2.98892e-05
|
|
|
PFIC2
|
[NCBI]
|
2.98892e-05
|
|
|
IDDM12
|
[NCBI]
|
2.98892e-05
|
|
|
NEM1
|
[NCBI]
|
2.98892e-05
|
|
|
DFNA10
|
[NCBI]
|
2.98892e-05
|
|
|
CSCD
|
[NCBI]
|
2.98892e-05
|
|
|
RTADR
|
[NCBI]
|
2.98892e-05
|
|
|
hydroxyacyl-coa dehydrogenase ii deficiency
|
[NCBI]
|
2.98892e-05
|
|
|
pyogenic sterile arthritis, pyoderma gangrenosum, and acne
|
[NCBI]
|
2.98892e-05
|
|
|
PGL3
|
[NCBI]
|
2.98892e-05
|
|
|
watson syndrome
|
[NCBI]
|
2.98892e-05
|
|
|
LVNC1
|
[NCBI]
|
2.98892e-05
|
|
|
DFNB2
|
[NCBI]
|
2.98892e-05
|
|
|
STL3
|
[NCBI]
|
2.98892e-05
|
|
|
myopathy, centronuclear, autosomal recessive
|
[NCBI]
|
2.98892e-05
|
|
|
dentinogenesis imperfecta, shields type iii
|
[NCBI]
|
2.98892e-05
|
|
|
vasculopathy, retinal, with cerebral leukodystrophy
|
[NCBI]
|
2.98892e-05
|
|
|
neurofibromatosis, familial spinal
|
[NCBI]
|
2.98892e-05
|
|
|
JAE
|
[NCBI]
|
2.98892e-05
|
|
|
NAIC
|
[NCBI]
|
2.98892e-05
|
|
|
DFNA13
|
[NCBI]
|
2.98892e-05
|
|
|
retinitis pigmentosa, x-linked, with recurrent respiratory infections
|
[NCBI]
|
2.98892e-05
|
|
|
KRS
|
[NCBI]
|
2.98892e-05
|
|
|
hypophosphatemic rickets, x-linked recessive
|
[NCBI]
|
2.98892e-05
|
|
|
keratosis palmoplantaris striata i
|
[NCBI]
|
2.98892e-05
|
|
|
RP15
|
[NCBI]
|
2.98892e-05
|
|
|
weyers acrofacial dysostosis
|
[NCBI]
|
2.98892e-05
|
|
|
ebstein anomaly
|
[NCBI]
|
2.98892e-05
|
|
|
MRX59
|
[NCBI]
|
2.98892e-05
|
|
|
CMD1D
|
[NCBI]
|
2.98892e-05
|
|
|
PC2
|
[NCBI]
|
2.98892e-05
|
|
|
ramon syndrome
|
[NCBI]
|
2.98892e-05
|
|
|
AIHHT
|
[NCBI]
|
2.98892e-05
|
|
|
3-@methylglutaconic aciduria, type iii
|
[NCBI]
|
2.98892e-05
|
|
|
DFNA17
|
[NCBI]
|
2.98892e-05
|
|
|
dentin dysplasia, type ii
|
[NCBI]
|
2.98892e-05
|
|
|
CDHS
|
[NCBI]
|
2.98892e-05
|
|
|
PDB1
|
[NCBI]
|
2.98892e-05
|
|
|
DRD2
|
[NCBI]
|
2.97139e-05
|
|
|
ELAC2
|
[NCBI]
|
2.96867e-05
|
|
|
LYST
|
[NCBI]
|
2.96867e-05
|
|
|
ATP1A2
|
[NCBI]
|
2.96867e-05
|
|
|
NPS
|
[NCBI]
|
2.94808e-05
|
|
|
AR
|
[NCBI]
|
2.92278e-05
|
|
|
MLC
|
[NCBI]
|
2.91575e-05
|
|
|
CLN1
|
[NCBI]
|
2.91575e-05
|
|
|
diastrophic dysplasia
|
[NCBI]
|
2.91575e-05
|
|
|
KEL
|
[NCBI]
|
2.89878e-05
|
|
|
BRRS
|
[NCBI]
|
2.85775e-05
|
|
|
IL6R
|
[NCBI]
|
2.83302e-05
|
|
|
NEFL
|
[NCBI]
|
2.83302e-05
|
|
|
SPG7
|
[NCBI]
|
2.83302e-05
|
|
|
alcohol dependence
|
[NCBI]
|
2.77791e-05
|
|
|
LMX1B
|
[NCBI]
|
2.77095e-05
|
|
|
SPR
|
[NCBI]
|
2.77095e-05
|
|
|
FLT4
|
[NCBI]
|
2.77095e-05
|
|
|
FUT2
|
[NCBI]
|
2.77095e-05
|
|
|
PCDH15
|
[NCBI]
|
2.77095e-05
|
|
|
NF2
|
[NCBI]
|
2.77021e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
2.75166e-05
|
|
|
WNK1
|
[NCBI]
|
2.71219e-05
|
|
|
CCM
|
[NCBI]
|
2.68533e-05
|
|
|
FCMD
|
[NCBI]
|
2.68533e-05
|
|
|
trichoepithelioma, multiple familial
|
[NCBI]
|
2.68366e-05
|
|
|
OSCS
|
[NCBI]
|
2.68366e-05
|
|
|
MKS2
|
[NCBI]
|
2.68366e-05
|
|
|
hereditary motor and sensory neuropathy v
|
[NCBI]
|
2.68366e-05
|
|
|
fanconi renotubular syndrome
|
[NCBI]
|
2.68366e-05
|
|
|
hemangioma, capillary infantile
|
[NCBI]
|
2.68366e-05
|
|
|
PGL2
|
[NCBI]
|
2.68366e-05
|
|
|
vestibulopathy, familial
|
[NCBI]
|
2.68366e-05
|
|
|
SCZD10
|
[NCBI]
|
2.68366e-05
|
|
|
STHAG4
|
[NCBI]
|
2.68366e-05
|
|
|
myopathy with deficiency of succinate dehydrogenase and aconitase
|
[NCBI]
|
2.68366e-05
|
|
|
macular edema, cystoid
|
[NCBI]
|
2.68366e-05
|
|
|
NNO1
|
[NCBI]
|
2.68366e-05
|
|
|
CFTR
|
[NCBI]
|
2.67926e-05
|
|
|
DFNB7
|
[NCBI]
|
2.62593e-05
|
|
|
LIS2
|
[NCBI]
|
2.62593e-05
|
|
|
ectopia lentis, isolated
|
[NCBI]
|
2.62593e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2b1
|
[NCBI]
|
2.62593e-05
|
|
|
DFNA4
|
[NCBI]
|
2.62593e-05
|
|
|
MRXSL
|
[NCBI]
|
2.62593e-05
|
|
|
HDL1
|
[NCBI]
|
2.62593e-05
|
|
|
scapuloperoneal syndrome, neurogenic, kaeser type
|
[NCBI]
|
2.62593e-05
|
|
|
CCM2
|
[NCBI]
|
2.62593e-05
|
|
|
CGL1
|
[NCBI]
|
2.62593e-05
|
|
|
MONA
|
[NCBI]
|
2.62593e-05
|
|
|
basal ganglia disease, adult-onset
|
[NCBI]
|
2.62593e-05
|
|
|
MRT1
|
[NCBI]
|
2.62593e-05
|
|
|
DFNB18
|
[NCBI]
|
2.62593e-05
|
|
|
CNA2
|
[NCBI]
|
2.62593e-05
|
|
|
intestinal pseudoobstruction, neuronal, chronic idiopathic, x-linked
|
[NCBI]
|
2.62593e-05
|
|
|
peters anomaly
|
[NCBI]
|
2.62593e-05
|
|
|
alternating hemiplegia of childhood
|
[NCBI]
|
2.62593e-05
|
|
|
RP14
|
[NCBI]
|
2.62593e-05
|
|
|
nasopharyngeal carcinoma
|
[NCBI]
|
2.62593e-05
|
|
|
cataract, lamellar
|
[NCBI]
|
2.62593e-05
|
|
|
EVR4
|
[NCBI]
|
2.62593e-05
|
|
|
leukodystrophy, adult-onset, autosomal dominant
|
[NCBI]
|
2.62593e-05
|
|
|
RP17
|
[NCBI]
|
2.62593e-05
|
|
|
complement component 8 deficiency, type i
|
[NCBI]
|
2.60335e-05
|
|
|
ATR
|
[NCBI]
|
2.55275e-05
|
|
|
TCOF1
|
[NCBI]
|
2.55275e-05
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
2.52441e-05
|
|
|
ARPKD
|
[NCBI]
|
2.52315e-05
|
|
|
HHIP
|
[NCBI]
|
2.47583e-05
|
|
|
ZFAT1
|
[NCBI]
|
2.47583e-05
|
|
|
GPR92
|
[NCBI]
|
2.47583e-05
|
|
|
NDUFV3
|
[NCBI]
|
2.47583e-05
|
|
|
TTC8
|
[NCBI]
|
2.47583e-05
|
|
|
ADAM29
|
[NCBI]
|
2.47583e-05
|
|
|
respiratory rhythmicity in sleep
|
[NCBI]
|
2.47583e-05
|
|
|
TBCD
|
[NCBI]
|
2.47583e-05
|
|
|
CHRM4
|
[NCBI]
|
2.47583e-05
|
|
|
PCDH9
|
[NCBI]
|
2.47583e-05
|
|
|
CTPP4
|
[NCBI]
|
2.47583e-05
|
|
|
TMEM142C
|
[NCBI]
|
2.47583e-05
|
|
|
NEURL
|
[NCBI]
|
2.47583e-05
|
|
|
MMP24
|
[NCBI]
|
2.47583e-05
|
|
|
ZC3H12D
|
[NCBI]
|
2.47583e-05
|
|
|
DCTN3
|
[NCBI]
|
2.47583e-05
|
|
|
SSBP1
|
[NCBI]
|
2.47583e-05
|
|
|
GABRG1
|
[NCBI]
|
2.47583e-05
|
|
|
TMEM142B
|
[NCBI]
|
2.47583e-05
|
|
|
PRKAR2A
|
[NCBI]
|
2.47583e-05
|
|
|
MPP4
|
[NCBI]
|
2.47583e-05
|
|
|
HYLS1
|
[NCBI]
|
2.47583e-05
|
|
|
OTOA
|
[NCBI]
|
2.47583e-05
|
|
|
SPG11
|
[NCBI]
|
2.47583e-05
|
|
|
LAPTM5
|
[NCBI]
|
2.47583e-05
|
|
|
KCNQ1DN
|
[NCBI]
|
2.47583e-05
|
|
|
OPA3
|
[NCBI]
|
2.47583e-05
|
|
|
ZNF79
|
[NCBI]
|
2.47583e-05
|
|
|
ERV3
|
[NCBI]
|
2.47583e-05
|
|
|
cytochrome p450, family 4, subfamily v, polypeptide 2
|
[NCBI]
|
2.47583e-05
|
|
|
CVID
|
[NCBI]
|
2.47507e-05
|
|
|
PTEN
|
[NCBI]
|
2.46954e-05
|
|
|
LEP
|
[NCBI]
|
2.4182e-05
|
|
|
CTSK
|
[NCBI]
|
2.37118e-05
|
|
|
NPPA
|
[NCBI]
|
2.35756e-05
|
|
|
BBS
|
[NCBI]
|
2.34869e-05
|
|
|
pancreatic cancer, susceptibility to, 1
|
[NCBI]
|
2.33087e-05
|
|
|
CLN6
|
[NCBI]
|
2.33087e-05
|
|
|
cardiomyopathy, familial hypertrophic, with wolff-parkinson-white syndrome
|
[NCBI]
|
2.33087e-05
|
|
|
hypotrichosis simplex of scalp
|
[NCBI]
|
2.33087e-05
|
|
|
NEM2
|
[NCBI]
|
2.33087e-05
|
|
|
CO
|
[NCBI]
|
2.33087e-05
|
|
|
legg-calve-perthes disease
|
[NCBI]
|
2.33087e-05
|
|
|
ALS4
|
[NCBI]
|
2.33087e-05
|
|
|
acromesomelic dysplasia, hunter-thompson type
|
[NCBI]
|
2.33087e-05
|
|
|
pierson syndrome
|
[NCBI]
|
2.33087e-05
|
|
|
FSGS1
|
[NCBI]
|
2.33087e-05
|
|
|
FHL2
|
[NCBI]
|
2.33087e-05
|
|
|
LGMD2J
|
[NCBI]
|
2.33087e-05
|
|
|
avascular necrosis of femoral head, primary
|
[NCBI]
|
2.33087e-05
|
|
|
cardiomyopathy, dilated, with woolly hair and keratoderma
|
[NCBI]
|
2.33087e-05
|
|
|
CCM3
|
[NCBI]
|
2.33087e-05
|
|
|
polymicrogyria, bilateral frontoparietal
|
[NCBI]
|
2.33087e-05
|
|
|
SPMM
|
[NCBI]
|
2.33087e-05
|
|
|
CPVT
|
[NCBI]
|
2.33087e-05
|
|
|
CORD3
|
[NCBI]
|
2.33087e-05
|
|
|
EAD
|
[NCBI]
|
2.33087e-05
|
|
|
deafness, congenital, with keratopachydermia and constrictions of fingers and toes
|
[NCBI]
|
2.33087e-05
|
|
|
SLC17A7
|
[NCBI]
|
2.33021e-05
|
|
|
TNNT2
|
[NCBI]
|
2.33021e-05
|
|
|
IFNGR1
|
[NCBI]
|
2.33021e-05
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
2.29668e-05
|
|
|
KRT14
|
[NCBI]
|
2.29077e-05
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
2.22122e-05
|
|
|
complement component 6 deficiency
|
[NCBI]
|
2.21604e-05
|
|
|
ATRX
|
[NCBI]
|
2.1913e-05
|
|
|
DCN
|
[NCBI]
|
2.18058e-05
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
2.17884e-05
|
|
|
MPZ
|
[NCBI]
|
2.17061e-05
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
2.17061e-05
|
|
|
MYOZ2
|
[NCBI]
|
2.16686e-05
|
|
|
HS1BP3
|
[NCBI]
|
2.16686e-05
|
|
|
STOX1
|
[NCBI]
|
2.16686e-05
|
|
|
ERDA1
|
[NCBI]
|
2.16686e-05
|
|
|
GNPTG
|
[NCBI]
|
2.16686e-05
|
|
|
MMP17
|
[NCBI]
|
2.16686e-05
|
|
|
CDH16
|
[NCBI]
|
2.16686e-05
|
|
|
RRH
|
[NCBI]
|
2.16686e-05
|
|
|
INA
|
[NCBI]
|
2.16686e-05
|
|
|
RHOD
|
[NCBI]
|
2.16686e-05
|
|
|
acidic cluster protein, 33-kd
|
[NCBI]
|
2.16686e-05
|
|
|
GPR78
|
[NCBI]
|
2.16686e-05
|
|
|
EVER2
|
[NCBI]
|
2.16686e-05
|
|
|
EPR1
|
[NCBI]
|
2.16686e-05
|
|
|
ATP6V0A4
|
[NCBI]
|
2.16686e-05
|
|
|
CPSF1
|
[NCBI]
|
2.16686e-05
|
|
|
BARHL1
|
[NCBI]
|
2.16686e-05
|
|
|
OTOG
|
[NCBI]
|
2.16686e-05
|
|
|
P2RX5
|
[NCBI]
|
2.16686e-05
|
|
|
CCT4
|
[NCBI]
|
2.16686e-05
|
|
|
RRM2B
|
[NCBI]
|
2.16686e-05
|
|
|
IGLP1
|
[NCBI]
|
2.16686e-05
|
|
|
CYP2F1
|
[NCBI]
|
2.16686e-05
|
|
|
CPSF2
|
[NCBI]
|
2.16686e-05
|
|
|
HMG20B
|
[NCBI]
|
2.16686e-05
|
|
|
TMEM16E
|
[NCBI]
|
2.16686e-05
|
|
|
CERKL
|
[NCBI]
|
2.16686e-05
|
|
|
LCA5
|
[NCBI]
|
2.16686e-05
|
|
|
CACNG1
|
[NCBI]
|
2.16 |